A woman with short silver hair in a white shirt
Home / Procedures / Neck lift / Facelift and neck lift after nonsurgical treatment and GLP-1 weight loss

Facelift and neck lift after nonsurgical treatment and GLP-1 weight loss

Fat-dissolving injections, fat freezing, energy devices and threads can leave scar tissue in the neck that makes a later neck lift longer and deeper, with contour irregularities afterward. Weight loss on GLP-1 drugs such as semaglutide and tirzepatide takes fat mostly from the superficial layer of the face, so surgery after it has to deal with lost volume as well as loose skin.

What it is

This is a neck lift or facelift in a person whose tissue has already been changed by treatment or by weight loss. In O'Daniel's 2023 practice, about 2 in 3 neck lift patients had already had some neck treatment, surgical or nonsurgical (PMID 40712094). The earlier treatments include:

Changes after nonsurgical treatment

At surgery after nonsurgical neck treatment, surgeons find scar tissue (fibrosis), lost boundaries between tissue layers, a stiff platysma muscle and deep fascia, and fat left in unpredictable places (PMID 40712094). Skin-tightening devices aim at the superficial fascia, a layer only a few millimeters under the skin; it lies closer to the surface in the neck than in the cheek, and closer with age (PMID 30882511). Permanent filler brings its own problems: before a facelift, most patients with permanent filler had an uneven face, and about 1 in 4 had disfiguring swelling (PMID 36110395).

Changes after GLP-1 weight loss

Midface volume falls about 7% for every 10 kg of weight lost, mostly from the superficial fat pads (PMID 40407186). The change reaches every layer: superficial fat deflates, deep support weakens, bone resorbs and skin loosens (PMID 42210888). The drugs also reduce the fat in and under the skin and change the stem cells in fat, which may weaken the skin and reduce facial muscle (PMID 38874170). "Ozempic face" is the lay term for the hollowing, wrinkles and sagging that can follow (PMID 37541662).

Where it came from

Nonsurgical neck treatments spread as alternatives to surgery, marketed as safe and effective (PMID 40712094). Deoxycholic acid was approved by the FDA to reduce fat under the chin (PMID 31860219). Patients also started earlier: in one practice, facelift patients under 50 had begun injections, lasers and devices in their late 30s and had spent an average of $7,000 before choosing surgery (PMID 27965217). Permanent fillers were once used for wrinkles, and removing them became a problem for surgeons planning a facelift (PMID 36110395).

Facelift surgeons already treated deflated faces with inelastic skin after massive weight loss. In 2019 they described the changes needed: wide undermining of the face and neck, longer incisions behind the ear, treatment of the SMAS and platysma, and fat transfer to the cheek (PMID 30447822, PMID 31514808).

GLP-1 drugs became popular for weight loss after clinical trials showed how much weight people lost (PMID 40626110). In 2023 facial plastic surgeons wrote about "Ozempic face" and noted that prescribers seldom warn patients about the effect on the face (PMID 37541662). Online searches for "Ozempic face" rose together with searches for face filler and plastic surgeons (PMID 40626110). In 2025 a Vanderbilt team gave one of the first measurements of the volume loss, on CT and MRI scans (PMID 40407186).

In 2026 O'Daniel and Patton reported what earlier nonsurgical treatment does inside the neck at surgery (PMID 40712094). Also in 2026, a patient safety group of the International Society of Aesthetic Plastic Surgery (ISAPS), O'Daniel among its authors, set out the challenges and strategy for a facelift after fillers and energy devices (PMID 42321446).

Who it suits

  • A neck treated with injections, fat freezing, devices or threads. A neck lift is still possible, and surgeons plan for a harder operation and counsel patients on the added risk beforehand (PMID 40712094).
  • Permanent filler in the face. The filler can be removed during the facelift, under local anesthesia, with satisfactory results (PMID 36110395).
  • Under 50 after years of injectables. Patients who moved on to a facelift felt it took off more years than their nonsurgical treatment had (PMID 27965217).
  • Loose, deflated skin after major weight loss. A facelift can improve the neck and jawline and lower apparent age, though fully correcting the face is hard (PMID 31514808). Staged or added procedures may be needed, and surgeons discuss this beforehand (PMID 30447822).
  • Still losing weight on a GLP-1 drug. Facial volume keeps falling as weight falls (PMID 40407186). Significant weight loss after surgery is one reason O'Daniel's practice gives PLLA injections after a facelift (PMID 35662905).

How it is done

Neck lift after nonsurgical treatment

In O'Daniel's series, nearly every operation was a deep neck lift (deep cervicoplasty) that treats the structures under the platysma muscle (PMID 40712094). Operating time was longer in every case (PMID 40712094). Surgeons adapt the technique to scarred tissue and plan from a thorough examination before surgery (PMID 40712094).

Facelift after fillers and devices

Permanent filler can be removed under local anesthesia during a short-scar facelift with SMAS plication; the length of the operation depended on the skin and on how severe the filler problem was (PMID 36110395).

After major weight loss

Wide undermining of the face and neck is the most important step, because it allows the extra skin to be removed and redraped (PMID 31514808). Surgeons extend the incisions behind the ear, treat the SMAS and platysma in every case, and transfer fat into the deep cheek to restore the midface (PMID 30447822).

Replacing lost volume

Fat grafting is the usual surgical way to restore facial volume, but the biology of GLP-1 drugs may work against graft survival, and no study has yet measured graft results in people taking them (PMID 42219269). Collagen-stimulating injections are another option: PLLA restored volume after a facelift with fat grafting, with no nodules or granulomas reported (PMID 35662905). Diluted calcium hydroxylapatite (Radiesse) kept the lower face stable at 6 months in a small series of GLP-1 users who were still losing weight (PMID 41127050). A 2026 review advises starting collagen stimulation early and adding hyaluronic acid filler where support is lost (PMID 42210888).

GLP-1 drugs and anesthesia

GLP-1 drugs slow stomach emptying, which matters under general anesthesia (PMID 37541662). Guidance from the anesthesia, surgery and gastroenterology societies says the drug may be continued before surgery in patients without added risk of delayed stomach emptying and aspiration (PMID 39482213, Kindel 2025 full text). When it is held, a daily dose is skipped on the day of surgery and a weekly dose a week before (Kindel 2025 full text). A liquid diet for at least 24 hours before surgery is an option when slow stomach emptying is a concern (Kindel 2025 full text).

Results and how long they last

  • Neck lift after nonsurgical treatment. No major complications occurred, but nearly all patients had contour irregularities after surgery, from the fat and platysma the earlier treatment had destroyed (PMID 40712094).
  • Facelift with permanent filler removal. Results were satisfactory, and about 3 in 5 patients were satisfied (PMID 36110395).
  • Facelift after nonsurgical treatment. Patients under 50 felt they looked about 8 years younger after their facelift (PMID 27965217). Nonsurgical treatment alone had taken off about 4 years (PMID 27965217). Most did not regret what they had spent on it (PMID 27965217).
  • After GLP-1 weight loss. Facial volume falls with each kilogram lost (PMID 40407186), so weight lost after surgery shows in the face (PMID 35662905). Collagen-stimulating injections hold volume: PLLA after a facelift with fat grafting (PMID 35662905), and diluted calcium hydroxylapatite in GLP-1 users still losing weight, with every patient rated improved at 6 months (PMID 41127050).

Risks and how surgeons lower them

  • Contour irregularities. Nearly universal after a neck lift in a previously treated neck (PMID 40712094). Surgeons examine the neck closely and explain this risk before surgery (PMID 40712094).
  • Longer, harder surgery. Scar tissue and lost tissue planes lengthened every operation (PMID 40712094).
  • Thread problems. After thread lifts, threads can be seen or felt in about 1 in 10 patients (PMID 41988336). Skin dimpling follows in about 1 in 14 (PMID 41988336). Visible threads, dimpling and thread migration can last beyond the first four weeks (PMID 41988336). Thread-lift complications are also reported to the FDA's device database (PMID 37594003).
  • Permanent filler. It can leave an uneven face and disfiguring swelling; the filler can be removed during the facelift (PMID 36110395).
  • Fat grafts on GLP-1 drugs. Graft survival is untested, and the advice on managing the drugs around fat transfer is based on how the drugs act on fat (PMID 42219269).
  • Anesthesia on GLP-1 drugs. Delayed stomach emptying raises the concern of aspiration; the anesthesia guidance above sets when to hold the drug and when to use a liquid diet (PMID 37541662, Kindel 2025 full text).

Recovery

  • Removing permanent filler under local anesthesia was generally well tolerated (PMID 36110395).
  • Facial volume can keep changing after surgery while weight is still falling; PLLA injections after surgery are one way to replace it (PMID 35662905).
  • After major weight loss, a second stage or added procedures may follow the first operation (PMID 30447822).

Questions to ask a surgeon

  • I have had Kybella, CoolSculpting, radiofrequency or threads in my neck: how will that change my operation and my result? (PMID 40712094)
  • Will I need a deep neck lift that works under the platysma muscle? (PMID 40712094)
  • How much longer will my operation take because of earlier treatments? (PMID 40712094)
  • Can my permanent filler be removed during the facelift? (PMID 36110395)
  • I take semaglutide or tirzepatide: should I keep taking it before surgery, and do I need a liquid diet the day before? (PMID 39482213)
  • Should I reach my goal weight first, and what happens to my result if I keep losing weight? (PMID 35662905)
  • Will you use fat grafting while I take a GLP-1 drug, or a collagen-stimulating injection instead? (PMID 42219269)
  • Do you plan extra steps for loose skin after weight loss, such as wider undermining or longer incisions behind the ear? (PMID 30447822)

Open questions

  • No controlled study compares neck lift results with and without earlier nonsurgical treatment; the data come from one surgeon (PMID 40712094).
  • Fat graft survival in people taking GLP-1 drugs has not been measured (PMID 42219269).
  • When to operate after GLP-1 weight loss, at a stable weight or during treatment: no facelift study was found in a PubMed search on 2026-09-25 (https://pubmed.ncbi.nlm.nih.gov/); a 2025 review calls for practice guidelines (PMID 40626110).
  • Holding GLP-1 drugs before anesthesia rests on expert consensus (Kindel 2025 full text).
  • Collagen-stimulating injections for GLP-1 users rest on small case series (PMID 41127050).

Terms

  • GLP-1 receptor agonist (GLP-1 RA): drug class that includes semaglutide and tirzepatide (PMID 42219269).
  • "Ozempic face": lay term for facial volume loss, wrinkles and sagging with GLP-1 weight loss (PMID 37541662).
  • Deoxycholic acid (Kybella): injectable approved to reduce fat under the chin (PMID 31860219).
  • Cryolipolysis: fat reduction by cooling (PMID 40712094).
  • Radiofrequency-assisted lipolysis: device group that includes FaceTite and Morpheus8 (PMID 40712094).
  • Fibrosis: scar tissue within the treated layers (PMID 40712094).
  • Superficial fascia: the layer under the skin that skin-tightening devices target (PMID 30882511).
  • Deep cervicoplasty: neck lift that treats the structures under the platysma muscle (PMID 40712094).
  • Biostimulator: injectable that stimulates collagen, such as PLLA or calcium hydroxylapatite (PMID 41127050).
  • PLLA (poly-L-lactic acid): collagen-stimulating injectable used to maintain volume (PMID 35662905).
  • Undermining: freeing the skin from the tissue below so it can be redraped (PMID 31514808).

Papers

PMID First author Year Journal Title Finding
40712094 O'Daniel TG 2026 Aesthet Surg J Neck Lift After Nonsurgical Treatments: Fibrosis, Fat Loss, and Surgical Complexity. Earlier nonsurgical neck treatment: scar tissue, deep neck lift in nearly all, longer surgery
42321446 Cervantes A 2026 Aesthetic Plast Surg Facelift Surgery in Patients With Prior Dermal Fillers and Energy-Based Device Treatments: Challenges and Strategic Considerations. ISAPS patient safety group: facelift strategy after fillers and energy devices
40407186 Sharma RK 2025 Otolaryngol Head Neck Surg Radiographic Midfacial Volume Changes in Patients on GLP-1 Agonists. GLP-1: midface volume falls about 7% per 10 kg lost, mostly superficial fat
40626110 Daneshgaran G 2025 Aesthet Surg J Open Forum "Ozempic Face" in Plastic Surgery: A Systematic Review of the Literature on GLP-1 Receptor Agonist Mediated Weight Loss and Analysis of Public Perceptions. Searches for "Ozempic face" rose with searches for fillers and surgeons; guidelines needed
31860219 Lin MJ 2019 J Drugs Dermatol The Impact of Submental Deoxycholic Acid Injections on Neck Surgery. Deoxycholic acid injections for fat under the chin and later neck surgery
36110395 Alaslawi AAF 2022 Plast Reconstr Surg Glob Open Facelift Surgery after Permanent Filler: Outcomes after Removal of Permanent Filler under Local Anesthesia. Permanent filler removed during facelift: satisfactory results, about 3 in 5 satisfied
27965217 Jacono AA 2017 Aesthet Surg J Nonsurgical Facial Rejuvenation Procedures in Patients Under 50 Prior to Undergoing Facelift: Habits, Costs, and Results. Under 50: years of injectables first; facelift took off more years (landmark)
41988336 Zhou X 2026 Front Surg A meta-analysis of complications of thread lifting. Thread lifts: visible threads about 1 in 10, dimpling about 1 in 14
37594003 Albucker SJ 2023 J Cutan Med Surg "Weekend Facelifts" Gone Wrong: Retrospective Analysis of the MAUDE Database on Thread-Lifting Complications From 2003-2023. Thread-lift complications in the FDA device database
30882511 Casabona G 2019 Dermatol Surg Influence of Age, Sex, and Body Mass Index on the Depth of the Superficial Fascia in the Face and Neck. Superficial fascia lies a few millimeters deep, shallower with age
37541662 Humphrey CD 2023 Facial Plast Surg Implications of Ozempic and Other Semaglutide Medications for Facial Plastic Surgeons. "Ozempic face"; consider stopping the drug before general anesthesia
38874170 Ridha Z 2024 Aesthet Surg J Decoding the Implications of Glucagon-like Peptide-1 Receptor Agonists on Accelerated Facial and Skin Aging. GLP-1 drugs may age the face through fat and stem cell changes
42210888 Frank K 2026 Dermatol Surg GLP-1-Induced Weight Loss and the Face: Anatomical Mechanisms and Rationale for Collagen-Stimulating and Volumizing Aesthetic Treatments. GLP-1 weight loss changes every facial layer; early collagen stimulation advised
42219269 Chalhoub X 2026 Aesthet Surg J Do GLP-1 Receptor Agonists Sabotage Fat Grafts? : A Scoping Review of GLP-1 Receptor Agonist Effects on Adipocyte Biology and Implications for Autologous Fat Transfer. GLP-1 drugs and fat grafts: no outcome studies; biology may reduce graft take
41127050 Durairaj KK 2025 Aesthet Surg J Open Forum Hyperdilute Radiesse Preserves Facial Volume in Glucagon-Like Peptide-1 Receptor Agonist Users Undergoing Rapid Weight Loss. Diluted calcium hydroxylapatite kept facial volume in GLP-1 users losing weight
35662905 O'Daniel TG 2022 Aesthet Surg J Open Forum The Utilization of Poly-l-Lactic Acid as a Safe and Reliable Method for Volume Maintenance After Facelift Surgery With Fat Grafting. PLLA restores volume after facelift with fat grafting; weight loss an indication
31514808 Couto RA 2019 Clin Plast Surg Facelift in Patients with Massive Weight Loss. Facelift after massive weight loss: wide undermining is the key step (landmark)
30447822 Waltzman JT 2019 Clin Plast Surg Face and Neck Lifting After Weight Loss. Wider undermining, longer incisions, SMAS and platysma treatment, fat transfer (landmark)
39482213 Kindel TL 2024 Surg Obes Relat Dis Multisociety clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period. Multisociety guidance on GLP-1 drugs around surgery

Papers cited

Newest first.

2026
Facelift Surgery in Patients With Prior Dermal Fillers and Energy-Based Device Treatments: Challenges and Strategic Considerations
Cervantes A, O'Daniel G, Auersvald L, Pacifico M, Baptista-Fernandes T, Torres B, et al. · Aesthetic Plast Surg · PMID 42321446
2019
The Impact of Submental Deoxycholic Acid Injections on Neck Surgery
Lin MJ, Dubin DP, Schwarcz RM, Khorasani H · J Drugs Dermatol · PMID 31860219